Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Market sentiment signals for CRISPR Therapeutics (CRSP): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Buy
29 analysts
Options Flow (P/C)
—
Avg Consensus PT
$72
+26.6%
Highest Price Target
$120
+110.3%
Lowest Price Target
$32
-43.9%
Short Interest
22.3%
Declining — Bullish
Insider Activity (30d)
—
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Aug 4, 2026 | Citigroup | Yigal Nochomovitz— | +54.3% | $82 → $88 | Maintained | Buy |
| Jul 8, 2026 | HC Wainwright & Co. | Mitchell S. Kapoor— | +40.2% | $80 → $80 | Maintained | Buy |